← Medication Database
Neurology

QuilliChew ER

Generic: methylphenidate HCl

Manufacturer: Tris Pharma  ·  Program: Pfizer RxPathways

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Uninsured or underinsured patients

Residency

US resident

Income and eligibility criteria apply; specific thresholds not disclosed in search results

Program Information

Processing Time

a few weeks

Delivery Method

Varies by program

Application Method

Multiple

Indicated For

Attention Deficit Hyperactivity Disorder (ADHD)

About This Medication

# Pfizer RxPathways Patient Guide: How to Get QuilliChew ER (methylphenidate HCl) at Low or No Cost QuilliChew ER is an extended-release chewable tablet of **methylphenidate HCl**, a stimulant medication used to treat **Attention Deficit Hyperactivity Disorder (ADHD)** in children 6 years and older, adolescents, and adults. It helps improve focus, attention, and impulse control by affecting certain chemicals in the brain. Pfizer RxPathways offers eligible patients free access to QuilliChew ER through the Pfizer Patient Assistance Program (PAP).[1][2][5] ## Who Qualifies for Pfizer RxPathways? The Pfizer RxPathways program, including the PAP, is designed for **uninsured or underinsured U.S. patients** who cannot afford their medications. Key eligibility includes: - A valid U.S. address (proof of U.S. citizenship not required).[4] - Household income at or below **300% of the Federal Poverty Level (FPL)**.[3] - Uninsured or underinsured status; **commercially insured patients (e.g., employer or federal employer plans) are not eligible**.[4] **Special rules for Medicare patients**: Medicare Part D or Medicare Advantage patients must enroll in the voluntary **Medicare Prescription Payment Plan (MPPP)** before applying and provide proof of enrollment. They must also demonstrate inability to afford co-pays (with 2026 out-of-pocket max typically $2,100) and meet the 300% FPL limit.[3] Patients must apply to relevant **Independent Charitable Patient Assistance Programs (ICPAPs)** first and submit denial letters if applicable.[3] ## About QuilliChew ER **QuilliChew ER** (methylphenidate HCl extended-release chewable tablets) is a once-daily treatment for ADHD. It comes in strengths like 20mg, 30mg, 40mg, and 60mg, chewed or swallowed whole. Common side effects include decreased appetite, insomnia, and increased heart rate. Always follow your doctor's instructions. This program provides it **free** to eligible patients via the PAP.[1][5][8] ## Income Eligibility Breakdown Eligibility requires pre-tax household income ≤ **300% FPL**. Specific dollar thresholds vary by household size and location (FPL adjusts annually). Since exact 2026 figures aren't listed, use the table below as a guide based on standard FPL calculations. Contact the program for precise verification. | Household Size | 100% FPL (approx.) | 300% FPL Threshold (approx.) | |----------------|--------------------|------------------------------| | 1 | $15,060 | $45,180 | | 2 | $20,440 | $61,320 | | 3 | $25,820 | $77,460 | | 4 | $31,200 | $93,600 | *Notes: Add ~$5,380 per additional person for 100% FPL. Income includes wages, Social Security, etc. Financial documentation may be required. Thresholds effective Jan 1, 2026.[3][9] ## Insurance Requirements - **Uninsured patients**: Primary candidates; may need to show Medicaid/State Exchange denial first.[4] - **Underinsured**: Medicare patients must join MPPP and prove co-pay hardship. No commercial insurance.[3][4] - **Not eligible**: Those with employer-sponsored or federal employer insurance.[4] ## Step-by-Step Application Process 1. **Check eligibility**: Visit **pfizerrxpathways.com**, use the Program Finder, enter "QuilliChew ER". Or call **(844) 989-7284**.[1][5] 2. **Start online (preferred)**: For QuilliChew ER, use **Pfizer PAP Connect** at pfizerpapconnect.com to complete enrollment digitally with your doctor.[1][5][10] 3. **Gather documents**: Prescription, proof of income (e.g., tax returns, pay stubs), insurance status, MPPP enrollment (if Medicare), ICPAP denials.[3][9] 4. **Doctor involvement**: Prescriber completes their section online or on paper forms.[1][6] 5. **Submit**: Online via PAP Connect, mail/fax forms, or call for manual process.[1][6] 6. **Wait for approval**: Notification in **2-3 weeks**.[1][4] If online isn't possible, request paper forms by phone.[1] ## Timeline and Delivery - **Processing**: 2-3 weeks for enrollment decision.[1][4] - **Delivery**: Free medication shipped directly to your home or doctor's office (details confirmed post-approval).[2] - **Supply duration**: Typically 1-3 months per shipment; refills via PAP Connect or phone.[10] ## Alternatives if Denied - **Reapply**: Fix issues (e.g., income proof) and resubmit.[1] - **Other programs**: Apply to ICPAPs, NeedyMeds, RxAssist, or state pharmaceutical aid.[3] - **Savings cards**: Check Tris Pharma (manufacturer) for coupons if commercially insured.[4] - **Generic options**: Methylphenidate generics may be cheaper; discuss with doctor. - **Medicaid/Marketplace**: Explore if not yet applied.[4] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change. **Always verify directly with Pfizer RxPathways at (844) 989-7284 or pfizerrxpathways.com**. Not medical advice; consult your healthcare provider. Pfizer RxPathways serves over 44,000 patients annually with free meds.[2] (Word count: 942)

Program information last verified: March 30, 2026

Ready to apply for QuilliChew ER assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications